$BMY News

B of A Securities Maintains Buy on Bristol-Myers Squibb, Lowers Price Target to $66

Is Bristol-Myers Squibb (BMY) Cheap As Index Changes Reshape Investor Exposure?

Bristol Myers Squibb (BMY) Expands QUILS Lung Cancer Detection Model Beyond Kentucky

Bristol-Myers Squibb’s Q2 2026 Earnings: What to Expect

Is Bristol Myers Squibb’s Shift Into Value-Defensive Indices Reshaping The Investment Case For BMY?

Bristol Myers Squibb (BMY) Stock Looks Cheap On Earnings But Mixed On Value

Cantor Fitzgerald Reiterates Neutral on Bristol-Myers Squibb, Maintains $54 Price Target

Bristol Myers Squibb: Pain First, Payoff Later?

Bristol-Myers Squibb: Cash Flow Machine, Outsized Growth Portfolio, And Inflation Beating Incomes

Bristol-Myers Squibb (BMY) Joins Arcus Biosciences to Test a New Two-Drug Kidney Cancer Combination

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Bristol Myers Squibb (BMY) Moves From Russell Growth Indexes To Value And Defensive

Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates?

Bristol Myers Squibb (BMY) Exceeds Market Returns: Some Facts to Consider

Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Play with Cautionary Notes

Does Bristol Myers Squibb’s 2026 Dividend and Pipeline Ambition Reframe Its Capital Priorities (BMY)?

Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note

Bristol-Myers Squibb Company (BMY) and SystImmune Announce Results from Analyses of Iza-bren Studies

3 Reasons to Buy Bristol Myers Squibb Stock

Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight